Novo Nordisk inks licensing agreement for oral weight loss drug candidate: Novo wants to find out if patients could benefit from a weight loss drug pill after they use one of its blockbuster GLP-1s.
Last month, M&M's launched its first loyalty program, Fun Club, allowing consumers to earn points by completing activities and redeem them for sweepstakes entries or M&M's merchandise. While loyalty programs are typically associated with high-frequency purchases—like groceries, travel, or restaurants—even low-frequency brands are using loyalty to increase engagement, gather data, and drive sales amid rising competition.
Creators get Cannes spotlight in 2025: With rebranded awards and new categories, Cannes Lions acknowledges the growing impact of creator-driven marketing.
Positivity pays on Pinterest: A new study determined that platforms deemed “positive” can significantly boost ad performance.
This leaves the BNPL industry back at square one in terms of regulation, creating uncertainty for providers
GOBankingRates research examines what young adults do with their paychecks.
61% of US consumers have used AI tools for online shopping: Retailers have a clear opportunity to leverage the technology for more personalized experiences.
Variable notification frequency comes to YouTube: The test could help brands reach audiences and drive purchase decisions—but will require them to adapt.
Walmart will invest $6 billion in Mexico this year: The move could protect it from growing anti-American sentiment.
Issuers can tap these models to reach a new customer segment and boost their credit card account openings
TikTok Shop expands in Europe as US fate remains uncertain: Launch in France, Germany, and Italy underscores push for growth amid pressure to boost sales.
The platform can help the card program better compete with traditional cards from large issuers
Android Auto chases connected car gaming, while Apple CarPlay bets on sports content and simplified interfaces. Both present new advertising opportunities.
Tesla’s at the center of a heated political battle, and insurers and their customers are paying the price.
Eli Lilly adds Alzheimer’s treatments, resources to D2C platform: Lilly is progressing its D2C online offerings even as lawmakers ramp up scrutiny of drugmaker-telehealth partnerships.
Consumers reject AI-written doctor’s notes: Patients' demand for transparent messaging from physicians is a reminder for pharma and healthcare companies to make sure their marketing messages are transparent too.
This year, high viewership demonstrates the enduring popularity of the events, name image likeness (NIL) rights are allowing athletes to take part in brand deals, and the women’s league continues to make a bigger splash than in years past.